PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to ...
PANTHERx® Rare, a leader in rare disease product patient access and support services in the United States, is pleased to announce that it was selected by Soleno Therapeutics as the specialty pharmacy ...
The legislation, SB 2385, filed by state Sen. David Koehler, D-Peoria, would curb PBM abuses by stopping steering, mandating ...
Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today ...
As managed care pharmacy navigates rapid transformations in policies, high-cost drug strategies, and innovative therapies, ...
The global US Healthcare Education Market is expected to reach US$61.44 billion by 2028 from US$39.24 billion in 2023, at a CAGR of 9.4% during the forecast period. The growth of the US healthcare ...
The chapter 11 bankruptcy cases of 23andMe Holding Co. and its affiliated debtors (collectively, “23andMe”), the company that ...
The Business Research Company The Business Research Company's Myocarditis Disease Global Market Report 2025 – Market Size, Trends, And Glob ...
We recently published a list of 20 Most Expensive Stocks Insiders Are Dumping In March. In this article, we are going to take ...
Zacks Investment Research on MSN1d
Here's Why You Should Retain OPKO Health Stock in Your PortfolioOPKO Health, Inc. OPK is well-poised for growth in the coming quarters, courtesy of its potential in RAYALDEE. The optimism ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback